超声造影对高危肝细胞癌患者MRI不确定观察的解决作用
研究纳入42例高危肝细胞癌患者共50个MRI不确定结节样观察和10个动脉期高增强灶,用超声造影按LI-RADS盲法分类并与病理及24个月随访对照。超声造影在14/37(38%)动脉期增强无廓清的结节中显示廓清,诊断16个恶性病灶(14个HCC、2个ICC),敏感度81.3%、特异度100%,36%患者LI-RADS从LR-3或4升级至LR-4或5。
要点
- 灰阶超声可识别真结节并与假病灶区分。
- 动态超声造影可检测廓清并正确预测HCC。
- MRI不确定时超声造影可作为问题解决工具。
核心结论
- 灰阶超声检测真结节,动态超声造影检测并定性廓清,正确预测HCC。
- 超声造影是MRI的补充,当MRI不确定时可作为问题解决工具。
研究设计与样本
- 研究类型为单中心连续病例队列,2015年7月至12月连续纳入42例因MRI不确定转诊超声造影的高危HCC患者。
- 共50个不确定结节样观察和10个动脉期高增强灶(提示假病灶/动门静脉分流)。
- MRI和超声造影按各期增强特征及LI-RADS盲法分类,行临床病理对照和24个月随访。
关键影像表现/征象
- 37/50(74%)不确定结节样观察在MRI上呈动脉期增强而无廓清。
- 超声造影进一步定性增强并在14/37(38%)中显示廓清。
- 10个MRI疑似动门静脉分流中,2个在超声上显示真结节,分别证实为HCC和再生结节。
诊断标准与关键数值
- 超声造影诊断16个恶性病灶(14例患者中14个HCC、2个ICC),其中12/16(75%)经活检或随访证实。
- 超声造影诊断恶性的敏感度为(13/16)81.3%,特异度为(37/37)100%。
- 15/42(36%)患者LI-RADS从MRI的LR-3或4升级至超声造影的LR-4或5。
临床应用与阅片要点
- 灰阶超声识别真结节,有助于将真结节与假病灶区分。
- 动态超声造影检测并定性廓清,可正确预测HCC。
- MRI不确定时,超声造影可作为补充的问题解决工具。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To show the contribution of CEUS to characterization of indeterminate MRI observations in high-risk patients for hepatocellular carcinoma (HCC).
METHODS: From July to December 2015, 42 consecutive patients referred to CEUS with indeterminate MRI scans comprise our study cohort. There are 50 indeterminate nodule-like observations and 10 arterial phase hyperenhancing foci, suggesting pseudolesions/arterio-portal shunts. MRI and CEUS lesions are classified according to their enhancement features in all phases and Liver Imaging and Reporting Data System (LI-RADS) in a blind read format. Clinical pathologic correlation and 24 months follow-up are performed.
RESULTS: A majority, 37/50 (74%), of indeterminate nodule-like observations have arterial phase enhancement without washout on MRI. CEUS further characterizes enhancement and shows washout in 14/37 (38%). In total, CEUS diagnoses 16 malignant lesions in 14 patients including 14 HCC and 2 ICC. 12/16 (75%) malignant lesions are confirmed by biopsy or follow-up. Ultrasound identification of a nodule differentiates real nodules from pseudolesions. Of the ten suspected arterial-portal shunts on MRI, two show a real nodule on ultrasound, confirmed as an HCC and a regenerative nodule. 15/42 (36%) patients have LI-RADS escalated from LR-3 or 4 on MRI to LR-4 or 5 on CEUS. Overall, the sensitivity of CEUS is (13/16) 81.3% and specificity is (37/37) 100% for malignant diagnosis.
CONCLUSION: Grayscale ultrasound detects true nodules. Dynamic CEUS detects and characterizes washout, correctly predicting HCC. CEUS is complimentary to MRI and can serve as a problem-solving tool when MRI is indeterminate.
引用
- Hu J, Bhayana D, Burak KW, et al. Resolution of indeterminate MRI with CEUS in patients at high risk for hepatocellular carcinoma. Abdom Radiol (NY). 2020. PMID: 31440801. doi:10.1007/s00261-019-02181-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。